Antigua and Barbuda vs Indonesia: Proportion of the target population who received
Antigua and Barbuda
82.0%
in 2024
Indonesia
82.0%
in 2024
Antigua and Barbuda rank
106th
Indonesia rank
106th
Proportion of the target population who received over time
- Antigua and Barbuda
- Indonesia
How they compare
Antigua and Barbuda currently reports 82.0% against 82.0% in Indonesia, a difference of 0.0%.
The two have swapped places 3 times across 20 shared years of data; in 2005 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 106th and Indonesia ranks 106th of 193 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.8% | 55.8% | 18.0% | Antigua and Barbuda |
| 2010s | 87.0% | 61.9% | 25.1% | Antigua and Barbuda |
| 2020s | 83.2% | 67.0% | 16.2% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Antigua and Barbuda or Indonesia?
- Antigua and Barbuda, at 82.0% against 82.0% in Indonesia as of 2024.
- What is the difference in proportion of the target population who received between Antigua and Barbuda and Indonesia?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Indonesia?
- 20 years are reported by both, from 2005 to 2024.
- How do Antigua and Barbuda and Indonesia rank globally for proportion of the target population who received?
- Antigua and Barbuda ranks 106th and Indonesia ranks 106th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.